.png)
Whole genome sequencing and Galleri pair inherited risk insights with multi-cancer early detection—connected by one year of personalized guidance in the Longevity AI App.
Why this bundle matters
No single test provides a complete view. Together, these three components help connect inherited risk, present-day screening, and ongoing understanding.
Clinical whole genome sequencing can identify inherited variants associated with cancer, cardiovascular conditions, and medication response. Risk is not certainty; results are interpreted in the context of your health history.
Explore whole genome sequencingA blood test screens for a shared cancer signal associated with more than 50 cancer types, complementing—not replacing—the routine screenings your healthcare provider recommends.
Explore the Galleri testThe Longevity AI App helps turn your results into personalized, ongoing guidance by supporting clearer questions, understanding, and planning. It does not replace care from a licensed physician.
What is included
Genomics looks at inherited risk. Galleri screens for present cancer signals. The Longevity AI App helps you understand your results and prepare for what comes next.
All 6.4 billion base pairs, sequenced at approximately 30× average coverage in a CLIA-certified laboratory from an at-home saliva kit.
A single two-tube blood draw screens for a shared signal associated with more than 50 cancer types, including many without routine screening today.
Ongoing understanding
Ask questions about your own genomic and health results in plain language. The app supports understanding and longitudinal planning, helping you arrive at clinical conversations with better questions.
The app supports—not replaces—care from a licensed physician.
The complete bundle
Genomics + Galleri® + one year of the Longevity AI App bring inherited risk, present-day screening, and ongoing understanding into one coordinated starting point.
$1,799 regular combined value
Contact HLI to request the bundle. We will review Galleri eligibility and coordinate the physician consultation and order.
Complete your Genomics saliva kit at home and schedule Galleri’s single two-tube blood draw.
Your genome is sequenced in a CLIA-certified laboratory, with results in 6–8 weeks. Galleri results are interpreted with physician guidance.
Use your physician-ready genomic report, Galleri guidance, and the Longevity AI App to understand your results and prepare for follow-up conversations.
Built on clinical evidence
From sequencing depth to test specificity, the bundle brings together clinically grounded tools with clearly defined roles—then supports understanding through the Longevity AI App.
Eligibility & safety
Galleri is generally intended for adults age 50 or older, or adults with an elevated risk for cancer. A physician order and consultation are required. Rx only.
Galleri does not detect all cancers and does not replace routine cancer screenings recommended by your healthcare provider. False positive and false negative results occur. A “No Cancer Signal Detected” result does not rule out cancer.
Genomic results describe inherited risk, not certainty. They should be interpreted in the context of your personal and family history with a qualified healthcare professional.
Galleri® is a registered trademark of GRAIL, Inc.
Frequently asked questions
Clinical whole genome sequencing, the Galleri multi-cancer early detection test, and one year of access to the Longevity AI App. The regular combined value is $1,799, so the bundle saves $500. No separate retail value is assigned to the app.
Genomics assesses inherited information that does not change, including cancer and cardiovascular risk and medication response. Galleri analyzes blood for a shared cancer signal associated with more than 50 cancer types. One looks at inherited risk; the other looks for present signals.
Genomics uses an at-home saliva kit. Galleri requires a scheduled two-tube blood draw and a physician order. Our team will guide you through coordination after you get in touch.
Genomics results are typically available in 6–8 weeks. Your Galleri result is reviewed with appropriate physician guidance; timing and next steps are coordinated as part of the process.
No. Galleri should be used in addition to routine recommended screenings, not instead of them. The test can produce false positive and false negative results and does not detect every cancer.
No. The Longevity AI App helps you ask questions about and understand your own results in plain language. It supports planning and physician conversations; it does not replace a physician.
Genomics + Galleri® + one year of Longevity AI
Connect with our team to confirm eligibility and coordinate all three parts of your bundle.